美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

OMNIAB INC C/WTS (TO PUR COM)

0.0751

0.0000

成交量：4.00

成交额：0.46

市值：- -

市盈率：-0.13

高：0.0751

开：0.0751

低：0.0751

收：0.0751

52周最高：0.6275

52周最低：0.0751

股本：- -

流通股本：- -

量比：0.10

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.5905

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

OMNIAB INC C/WTS (TO PUR COM)

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.omniab.com

邮编：

- -

电话：

- -

传真：

- -

简介：

OmniAb, Inc.于2015年12月14日根据特拉华州法律注册成立。OmniAb的发现平台为制药行业合作伙伴提供了获取各种抗体库和高通量筛选技术的途径，从而能够发现下一代疗法。OmniAb平台的核心是他们专有的转基因动物的Biological Intelligence（BI），包括OmniRat、OmniChicken和OmniMouse，这些动物经过基因改造，产生具有人类序列的抗体，以促进人类治疗候选药物的开发。OmniFlic（转基因大鼠）和OmniClic（转基因鸡）通过一种常见的轻链方法满足了行业对双特异性抗体应用的需求，而OmniTaur具有牛抗体对复杂靶点的独特结构属性。以离子通道和运输机为重点的既定核心能力进一步使其技术具有差异性，并在新兴目标类别中创造了机会。OmniAb抗体已被用于多种模式，包括双特异性抗体、抗体-药物偶联物等。OmniAb技术套件涵盖从BI驱动的库生成到尖端抗体发现和优化，为全球制药行业日益增长的发现需求提供了一种高效且可定制的端到端解决方案。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/OABIW/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OABIW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OABIW\",,,,,undefined,":{"symbol":"OABIW","market":"US","secType":"STK","nameCN":"OMNIAB INC C/WTS (TO PUR COM)","latestPrice":0.0751,"timestamp":1768597200000,"preClose":0.0751,"halted":0,"volume":4,"delay":0,"floatShares":0,"shares":0,"eps":-0.5905,"marketStatus":"休市中","change":0,"latestTime":"01-16 16:00:00 EST","open":0.0751,"high":0.0751,"low":0.0751,"amount":0.459899,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.5905,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768899600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0751,"volumeRatio":0.09615354567401592},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OABIW\",,,,,undefined,":{"symbol":"OABIW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.09615354567401592,"shares":0,"dividePrice":0,"high":0.0751,"amplitude":0,"preClose":0.0751,"low":0.0751,"week52Low":0.0751,"pbRate":"--","week52High":0.6275,"institutionHeld":0,"latestPrice":0.0751,"eps":-0.5905,"divideRate":0,"volume":4,"delay":0,"ttmEps":-0.5905,"open":0.0751,"prevYearClose":0.1199,"prevWeekClose":0.1199,"prevMonthClose":0.1199,"prevQuarterClose":0.1199,"fiveDayClose":0.1199,"twentyDayClose":0.11,"sixtyDayClose":0.168},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OABIW\",params:#limit:5,,,undefined,":[{"date":"2025-11-04","symbol":"OABIW","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1762290000000,"name":null,"time":"盘后","dateTimestamp":1762232400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OABIW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OABIW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.omniab.com","stockEarnings":[{"period":"1week","weight":-0.3736},{"period":"1month","weight":-0.3173},{"period":"3month","weight":-0.553},{"period":"6month","weight":-0.741},{"period":"1year","weight":-0.8322},{"period":"ytd","weight":-0.3736}],"compareEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":0.0302},{"period":"3month","weight":0.041},{"period":"6month","weight":0.1021},{"period":"1year","weight":0.1691},{"period":"ytd","weight":0.0143}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"OmniAb, Inc.于2015年12月14日根据特拉华州法律注册成立。OmniAb的发现平台为制药行业合作伙伴提供了获取各种抗体库和高通量筛选技术的途径，从而能够发现下一代疗法。OmniAb平台的核心是他们专有的转基因动物的Biological Intelligence（BI），包括OmniRat、OmniChicken和OmniMouse，这些动物经过基因改造，产生具有人类序列的抗体，以促进人类治疗候选药物的开发。OmniFlic（转基因大鼠）和OmniClic（转基因鸡）通过一种常见的轻链方法满足了行业对双特异性抗体应用的需求，而OmniTaur具有牛抗体对复杂靶点的独特结构属性。以离子通道和运输机为重点的既定核心能力进一步使其技术具有差异性，并在新兴目标类别中创造了机会。OmniAb抗体已被用于多种模式，包括双特异性抗体、抗体-药物偶联物等。OmniAb技术套件涵盖从BI驱动的库生成到尖端抗体发现和优化，为全球制药行业日益增长的发现需求提供了一种高效且可定制的端到端解决方案。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.035244},{"month":2,"riseRate":0.25,"avgChangeRate":-0.003001},{"month":3,"riseRate":0.25,"avgChangeRate":-0.017646},{"month":4,"riseRate":0,"avgChangeRate":-0.131109},{"month":5,"riseRate":0.25,"avgChangeRate":-0.052576},{"month":6,"riseRate":0.25,"avgChangeRate":-0.101946},{"month":7,"riseRate":1,"avgChangeRate":0.359887},{"month":8,"riseRate":0.5,"avgChangeRate":-0.002821},{"month":9,"riseRate":0,"avgChangeRate":-0.115532},{"month":10,"riseRate":0.4,"avgChangeRate":0.027488},{"month":11,"riseRate":0.2,"avgChangeRate":-0.198095},{"month":12,"riseRate":0.8,"avgChangeRate":0.286403}],"exchange":"NASDAQ","name":"OMNIAB INC C/WTS (TO PUR COM)","nameEN":"OMNIAB INC C/WTS (TO PUR COM)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"OABIW\",market:\"US\",,,undefined,":null}}